Mustang Bio
At Mustang Bio, we partner with leading academic institutions, with the goal of delivering next-generation therapies to patients in need worldwide.
Associated Experts
Job Title: Chief Technology Officer
Job Title: President and CEO
Associated Content
Mustang Bio’s gene therapy has tremendous potential to cure XSCID or Bubble Boy Disease based on study results from St. Jude
In this podcast, we interviewed Dr. Manny Litchman, President and CEO, Mustang Bio and Dr. Knut Niss, Chief Technology Officer, Mustang Bio about the exciting study results for their gene therapy candidate to treat X-SCID, why this disease is a good fit for gene therapy and next steps....Continued